Bank of Montreal Can Takes Position in Acadia Healthcare Co. (ACHC)
Bank of Montreal Can bought a new position in shares of Acadia Healthcare Co. (NASDAQ:ACHC) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 253,056 shares of the company’s stock, valued at approximately $14,020,000. Bank of Montreal Can owned 0.29% of Acadia Healthcare as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in ACHC. Pennant Capital Management LLC purchased a new position in shares of Acadia Healthcare during the first quarter valued at about $83,685,000. Legal & General Group Plc boosted its position in shares of Acadia Healthcare by 64.5% in the first quarter. Legal & General Group Plc now owns 5,064 shares of the company’s stock valued at $279,000 after buying an additional 1,986 shares in the last quarter. BlackRock Fund Advisors boosted its position in shares of Acadia Healthcare by 16.6% in the first quarter. BlackRock Fund Advisors now owns 776,809 shares of the company’s stock valued at $42,810,000 after buying an additional 110,692 shares in the last quarter. Arrowgrass Capital Partners US LP purchased a new position in shares of Acadia Healthcare during the first quarter valued at about $1,378,000. Finally, Geode Capital Management LLC boosted its position in shares of Acadia Healthcare by 41.5% in the first quarter. Geode Capital Management LLC now owns 473,045 shares of the company’s stock valued at $26,069,000 after buying an additional 138,635 shares in the last quarter.
Acadia Healthcare Co. (NASDAQ:ACHC) traded up 4.29% during mid-day trading on Friday, reaching $49.55. 1,616,175 shares of the company were exchanged. The stock’s 50-day moving average is $50.94 and its 200-day moving average is $55.13. The company has a market cap of $4.33 billion, a P/E ratio of 26.47 and a beta of 0.84. Acadia Healthcare Co. has a 12 month low of $46.99 and a 12 month high of $74.77.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Friday, July 29th. The company reported $0.73 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.73. Acadia Healthcare had a return on equity of 9.35% and a net margin of 6.44%. The business earned $756.50 million during the quarter, compared to analyst estimates of $752.57 million. During the same quarter last year, the company posted $0.57 EPS. Acadia Healthcare’s revenue for the quarter was up 66.8% on a year-over-year basis. Equities analysts expect that Acadia Healthcare Co. will post $2.63 earnings per share for the current year.
Several brokerages have issued reports on ACHC. Jefferies Group reissued a “buy” rating on shares of Acadia Healthcare in a research note on Sunday, July 17th. Robert W. Baird reissued an “outperform” rating and issued a $69.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, June 14th. RBC Capital Markets reissued an “outperform” rating and issued a $78.00 price objective (down from $86.00) on shares of Acadia Healthcare in a research note on Monday, August 1st. Leerink Swann restated an “outperform” rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Friday, July 15th. Finally, Royal Bank Of Canada decreased their target price on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating on the stock in a research report on Monday, August 1st. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and twelve have given a buy rating to the stock. Acadia Healthcare presently has a consensus rating of “Buy” and an average target price of $77.21.
In other Acadia Healthcare news, Director Reeve B. Waud sold 1,360,977 shares of the firm’s stock in a transaction dated Friday, September 16th. The stock was sold at an average price of $48.52, for a total transaction of $66,034,604.04. Following the completion of the sale, the director now directly owns 55,673 shares in the company, valued at approximately $2,701,253.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of the firm’s stock in a transaction dated Friday, September 16th. The stock was sold at an average price of $48.39, for a total value of $22,135,666.77. The disclosure for this sale can be found here. 17.20% of the stock is owned by corporate insiders.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Stock Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related stocks with our FREE daily email newsletter.